{"comparisonGroups":["Normal","Neural_Tube_Defect"],"dateCreated":"2025-09-26 00:00:00","display_title":"Normal vs neural tube defect condition","group_a_title":"Control samples with normal condition.. Provides a reference point for identifying metabolic differences due to neural tube defects.","group_b_title":"Experimental samples with neural tube defect condition.. Crucial for understanding the metabolic changes associated with neural tube defects.","id":"MTBLS4893_0002_00000003","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":1717,"studyId":"MTBLS4893","studyUrl":"http://integmet.org/study/MTBLS4893","title":"Normal_vs_Neural_Tube_Defect","topHits":[{"chebi_id":"81443","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"IHPJPQIRNONWGH-WLWVOYFZSA-N","pvalue":1.993155420373435e-09,"ratio":22336427401.96078,"synonym_name":""},{"chebi_id":"165553","direction":"up","inn_name":"","iupac_name":"(2S)-2-(hexadecanoylamino)-3-(1H-imidazol-5-yl)propanoic acid","metabolite_id":"XHUZOURAPKCNRA-FQEVSTJZSA-N","pvalue":1.5665450310207298e-08,"ratio":2785794377.073906,"synonym_name":""},{"chebi_id":"185837","direction":"up","inn_name":"","iupac_name":"4-O-[[3,4-dihydroxy-5-[[(2R,3S)-6-hydroxy-2-[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzouran-3-yl]oxy]-6-methoxyoxan-2-yl]methyl] 1-O-methyl butanedioate","metabolite_id":"DFDBQOBSZWTRTL-CDUOHFAZSA-N","pvalue":1.98996545777944e-08,"ratio":2120215650.3393664,"synonym_name":""},{"chebi_id":"2565","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"FIKOOQXJBAJJSE-YTQTXRHFSA-N","pvalue":9.438917610400557e-09,"ratio":745145893.6274508,"synonym_name":"Alectrol"},{"chebi_id":"168578","direction":"up","inn_name":"","iupac_name":"2-[[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-hexoxyoxane-3,4,5-triol","metabolite_id":"LOVPBJMHVBJKQS-UHFFFAOYSA-N","pvalue":4.1491933480885546e-08,"ratio":1177708724.3966815,"synonym_name":""},{"chebi_id":"46295","direction":"up","inn_name":"","iupac_name":"2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-<em>f</em>][1,2,4]triazin-4(1<em>H</em>)-one","metabolite_id":"SECKRCOLJRRGGV-UHFFFAOYSA-N","pvalue":1.061236240966157e-07,"ratio":3569492953.2428346,"synonym_name":"2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE"},{"chebi_id":"","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"MSTNYGQPCMXVAQ-PXYINDEMSA-N","pvalue":7.742882379590951e-08,"ratio":2321435158.936651,"synonym_name":""},{"chebi_id":"49703","direction":"up","inn_name":"","iupac_name":"(4<i>R</i>)-4-[(1<i>R</i>,4<i>Z</i>,8<i>Z</i>,10<i>S</i>,13<i>R</i>,15<i>R</i>)-15-hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl]-1,3-thiazolidin-2-one","metabolite_id":"NSHPHXHGRHSMIK-JRIKCGFMSA-N","pvalue":7.905253871962541e-07,"ratio":24123115452.865757,"synonym_name":"LATRUNCULIN B"},{"chebi_id":"186757","direction":"up","inn_name":"","iupac_name":"(E)-3-(3,4-dimethoxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]prop-2-enamide","metabolite_id":"OZNUPWACHHUIKC-JXMROGBWSA-N","pvalue":3.921248967222159e-07,"ratio":2387447303.0920053,"synonym_name":""},{"chebi_id":"183136","direction":"up","inn_name":"","iupac_name":"[(2R)-3-heptanoyloxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"RGIOGDXWJBHLCU-CQSZACIVSA-N","pvalue":6.261773257851167e-07,"ratio":2456535424.9999995,"synonym_name":""}],"totalFeatures":1992}